To further understand the roles of metabolic enzymes in a poorly understood neoplasm with dismal prognostic outcomes, this study showcases the utility of a genomics platform to understand the association between ketolytic and glycolytic gene expression profiles, MYCN amplification, INSS stage progression and event‐free survivability in NB. The gene discussed is MYCN; the disease is neoplasm.